Gainers
- Ensysce Biosciences (NASDAQ:ENSC) stock increased by 47.9% to $0.31 during Wednesday's pre-market session. The company's market cap stands at $11.8 million.
- TransCode Therapeutics (NASDAQ:RNAZ) shares moved upwards by 36.11% to $1.47. The market value of their outstanding shares is at $19.0 million.
- Accuray (NASDAQ:ARAY) shares moved upwards by 25.6% to $2.6. The company's market cap stands at $243.3 million.
- Adverum Biotechnologies (NASDAQ:ADVM) stock increased by 16.3% to $1.07. The company's market cap stands at $106.2 million.
- Cosmos Holdings (NASDAQ:COSM) shares moved upwards by 14.43% to $0.1. The market value of their outstanding shares is at $8.8 million.
- Geovax Labs (NASDAQ:GOVX) stock moved upwards by 14.21% to $1.0. The company's market cap stands at $24.6 million.
Losers
- ThermoGenesis Holdings (NASDAQ:THMO) shares fell 46.7% to $0.12 during Wednesday's pre-market session. The company's market cap stands at $3.7 million.
- Revelation Biosciences (NASDAQ:REVB) stock declined by 19.69% to $0.33. The company's market cap stands at $7.7 million.
- Taysha Gene Therapies (NASDAQ:TSHA) shares fell 15.44% to $2.52. The company's market cap stands at $103.5 million.
- Ocuphire Pharma (NASDAQ:OCUP) stock declined by 14.6% to $1.99. The market value of their outstanding shares is at $40.9 million.
- Calyxt (NASDAQ:CLXT) shares fell 11.46% to $0.15. The company's market cap stands at $7.0 million.
- Summit Therapeutics (NASDAQ:SMMT) shares decreased by 9.74% to $1.02. The market value of their outstanding shares is at $205.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
COSMCosmos Health Inc
$0.520016.6%
ENSCEnsysce Biosciences Inc
$0.9600-2.82%
GOVXGeovax Labs Inc
$2.932.45%
REVBRevelation Biosciences Inc
$0.8998-0.02%
RNAZTransCode Therapeutics Inc
$8.55-5.21%
SMMTSummit Therapeutics Inc
$17.43-1.25%
THMOThermoGenesis Holdings Inc
$0.000001-100.0%
TSHATaysha Gene Therapies Inc
$5.00-1.39%
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
